Crewe EB - Search Results

1

Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment.

Weltman MD, Brotodihardjo A, Crewe EB, Farrell GC, Bilous M, Grierson JM, Liddle C. Weltman MD, et al. Among authors: crewe eb. J Viral Hepat. 1995;2(1):39-45. doi: 10.1111/j.1365-2893.1995.tb00070.x. J Viral Hepat. 1995. PMID: 7493293 Clinical Trial.

2

Effects of interferon treatment response on liver complications of chronic hepatitis C: 9-year follow-up study.

Coverdale SA, Khan MH, Byth K, Lin R, Weltman M, George J, Samarasinghe D, Liddle C, Kench JG, Crewe E, Farrell GC. Coverdale SA, et al. Am J Gastroenterol. 2004 Apr;99(4):636-44. doi: 10.1111/j.1572-0241.2004.04085.x. Am J Gastroenterol. 2004. PMID: 15089895 Review.

3

Effects of hepatitis G virus coinfection on severity of hepatitis C: relationship to risk factors and response to interferon treatment.

Lin R, Dutta U, Kaba S, Kench J, Crewe E, Coverdale S, Byth K, Liddle C, Farrell GC. Lin R, et al. J Gastroenterol Hepatol. 1998 Aug;13(8):773-80. doi: 10.1111/j.1440-1746.1998.tb00732.x. J Gastroenterol Hepatol. 1998. PMID: 9736169

4

Which patients with hepatitis C develop liver complications?

Khan MH, Farrell GC, Byth K, Lin R, Weltman M, George J, Samarasinghe D, Kench J, Kaba S, Crewe E, Liddle C. Khan MH, et al. Hepatology. 2000 Feb;31(2):513-20. doi: 10.1002/hep.510310236. Hepatology. 2000. PMID: 10655279

5

Does hepatitis C virus play a role in "non-viral" chronic liver disease?

Liddle C, Crewe EB, Swanson NR, Jeffrey GP, Cunningham AL, Reed WD, Batey RG, Farrell GC. Liddle C, et al. Among authors: crewe eb. Med J Aust. 1990 Sep 3;153(5):265-71. doi: 10.5694/j.1326-5377.1990.tb136898.x. Med J Aust. 1990. PMID: 2118225

6

Changes in serum albumin during treatment of chronic hepatitis B with lamivudine: effects of response and emergence of drug resistance.

Hui JM, George J, Liddle C, Lin R, Samarasinghe D, Crewe E, Farrell GC. Hui JM, et al. Am J Gastroenterol. 2002 Apr;97(4):1003-9. doi: 10.1111/j.1572-0241.2002.05621.x. Am J Gastroenterol. 2002. PMID: 12003380

7

Changes in antipyrine clearance and platelet count, but not conventional liver tests, correlate with fibrotic change in chronic hepatitis C: value for predicting fibrotic progression.

Coverdale SA, Samarasinghe DA, Lin R, Kench J, Byth K, Khan MH, Crewe E, Liddle C, George J, Farrell GC. Coverdale SA, et al. Am J Gastroenterol. 2003 Jun;98(6):1384-90. doi: 10.1111/j.1572-0241.2003.07468.x. Am J Gastroenterol. 2003. PMID: 12818285

8

Hepatitis C virus in intravenous drug users.

Bell J, Batey RG, Farrell GC, Crewe EB, Cunningham AL, Byth K. Bell J, et al. Among authors: crewe eb. Med J Aust. 1990 Sep 3;153(5):274-6. doi: 10.5694/j.1326-5377.1990.tb136900.x. Med J Aust. 1990. PMID: 2118227

9

Molecular epidemiology of hepatitis C in Australia.

Kaba S, Dutta U, Byth K, Crewe EB, Khan MH, Coverdale SA, Lin R, Liddle C, Farrell GC. Kaba S, et al. Among authors: crewe eb. J Gastroenterol Hepatol. 1998 Sep;13(9):914-20. doi: 10.1111/j.1440-1746.1998.tb00761.x. J Gastroenterol Hepatol. 1998. PMID: 9794190

10

Hepatitis C virus infection in haemodialysis patients.

Roger SD, Crewe E, Cunningham A, Harris DC. Roger SD, et al. Aust N Z J Med. 1991 Feb;21(1):22-4. doi: 10.1111/j.1445-5994.1991.tb02996.x. Aust N Z J Med. 1991. PMID: 1852154

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page